Hone Health
Hone Health is a telehealth clinic offering hormone replacement therapy and personalized care plans based on advanced biomarker testing.
Secondary Market Price
Secondary Market Price
How Hone Health Measures Up
To help you manage your Hone Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are still gathering data and evaluating Hone Health's rating. Check back soon for our projection on the company's worth four years from now.
Exit Risk
TBD
We are still gathering data on Hone Health to train our machine learning model. Check back soon for our exit risk rating for Hone Health!
Funding Stage
Series A
A Series A funding round means Hone Health has a proven business model and is poised for significant growth. For a potential employee, this suggests more stability than an early-stage startup, along with ample opportunity to make an impact as the company scales.
Secondary Market Price Chart
The secondary market prices for Hone Health shown here are a limited preview. Create a free account to access real-time secondary market prices
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Hone Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Hone Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Hone Health is a digital health company that provides personalized hormone optimization and wellness support. The company operates as a telehealth clinic, offering services that include doctor consultations, advanced biomarker testing, and ongoing monitoring to create tailored treatment plans. These plans can involve prescription medications like hormone replacement therapy, lifestyle modifications, and nutritional guidance, which are delivered to a patient's home through a subscription service. Founded in 2018 by CEO Saad Alam, the New York-based company operates in the telehealth and health diagnostics sectors. It is a private, venture-backed company with 168 employees.
The company is focused on building out a comprehensive platform for proactive care, which it refers to as a "Personalized Operating System for Longevity." This system aims to connect diagnostics, data, and AI with medical expertise. A recent step in this direction is a partnership with Prenuvo, which allows Hone Health patients to book whole-body MRI scans through the Hone platform, integrating the imaging results with biomarker data for more precise care plans. The company has also been involved in public health discussions, such as participating in a CBS New York segment about the FDA's decision to remove the black box warning from menopause hormone therapy, highlighting it as a significant development for women's health.
- Gaingels
- FJ Labs
- Tribe Capital
- Republic Capital
- Co-Founder, CEO Mohammed Saad Alam
- Co-Founder, CMO Alba Mertira
- Co-Founder, CTO Matt Buckleman
- Co-Founder, COO Stuart Blitz
- Co-Founder, Director of Operations Seth Franz
- Co-Founder, Creative Director Zachary Kane
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Hone Health worth joining?
Deciding to join any startup involves evaluating your potential equity compensation alongside salary and company culture. Tools like Prospect can help you model the potential value of your equity offer to make a more informed decision.
What should I do with my Hone Health stock?
Managing private stock requires a strategy that considers your financial goals, tax implications, and the company's trajectory. Platforms like Prospect provide tools for scenario planning and tax optimization to help you decide when to hold or sell.
Can you sell Hone Health stock?
As a private company, Hone Health stock isn't traded on a public market, but selling opportunities can arise through company-approved tender offers or secondary market sales. Prospect offers tools to help you navigate these events and determine which shares are most tax-optimal to sell.
How can I find the value of my Hone Health stock?
The value of private stock is typically determined by a 409A valuation, which is updated periodically, often after a new funding round. To forecast potential future value, you can use services like Prospect, which employ predictive models based on venture capital data.
What is Hone Health's equity worth?
The precise worth of private equity fluctuates based on company performance, market conditions, and the most recent private valuation. You can use equity management platforms like Prospect to model different scenarios and project the potential post-tax value of your holdings.
What is Hone Health's stock ticker symbol?
Hone Health is a private company, so it does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell Hone Health stock?
Selling private stock is typically limited to specific events like tender offers, while buying is usually restricted to accredited investors during funding rounds. Employees can use platforms like Prospect to optimize their strategy for when selling opportunities become available.
What is the criteria to buy or invest in Hone Health stock?
Investing in a private company like Hone Health is generally reserved for institutional investors, venture capital firms, and accredited investors. Employees often receive equity as part of their compensation without needing to meet these investment criteria.
